The clinical trial process: the ultimate road to FDA approval. Success in clinical trials is the number one factor in determining the long-term viability of a biotech stock.

The clinical trial process is broken for a variety of reasons, ranging from the difficulty of designing trial protocols to the cost of running them. But one critical ...

In Alison’s case, her informed consent was a 90-minute on-site conversation that made her feel very comfortable about participating in the clinical trial process. Mashable Trend Report ...

New drugs take too long to get to market because of clinical trial bottlenecks. Two cancer doctors built AI-enabled tech to ...

Breaking Down the Clinical Trial Process. Clinical trials are the backbone of modern oncology, often determining the most effective primary treatment for various types of cancer.

Bringing a drug to market is a long and onerous process. Studies estimate that the clinical trial process — where new drugs are tested on patients before they are approved — lasts nine years ...

With a commitment to process optimization, training, and audits to enhance their operations, CROs can ensure the integrity of medications throughout the trial process. [Adobe Stock ...

The clinical trial software company announced Wednesday it raised $45 million in Series B funding to continue modernizing the process as the industry shifts to decentralized clinical trials.

The global clinical trials market size was estimated to be $44.3 billion in 2020 and predicted to rise to $69.3 billion by 2028, according to Grand View Research. Pharmaceutical and biotechnology ...

Ken Wallace, MBA, is president, Clinical Trial Marketing Communications (CTMC), and through a joint venture, vice president of operations, Integrated Clinical Trial Services (ICTS).

The next phase of COVID-19 vaccine research will take months. Moderna just started Phase 3 trials for its vaccine candidate and won’t expect results until late fall. The process takes time for a ...